Local startup Visual IQ‘s story begins with co-founder Manu Mathew’s frustrations as a marketer trying to understand how to best spend an advertising budget. He left his job managing the Boston office of the ad firm Carat to take “that marketer’s problem and turn it into a technology, data-driven solution,” he says. Visual IQ launched … Continue reading “Ad Tech Startup Visual IQ Adding NY Presence, Eyes Funding Round”
Category: Boston
CloudLock Secures $8,700,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=defa3c80-b162-438b-b9d7-4a42c96ae40e&Preview=1 Date 3/27/2012 Company Name CloudLock Mailing Address 203 Crescent Street Waltham, MA 02453 Company Description Headquartered in Waltham, Massachusetts, CloudLock is the cloud data protection company that enables control of data while gaining the collaboration and cost savings benefits of the cloud. Website http://www.cloudlock.com Transaction Type Venture Equity Transaction Amount $8,700,000 … Continue reading “CloudLock Secures $8,700,000 Series B Funding”
The iPhone Before the Apple iPhone
Ask most people to tell you the story of the iPhone, and you’ll likely hear about how an innovative computer company took the traditional telephone, combined it with the Internet, and came up with an attractive and low-cost device that pioneered a new category of touch screen hardware, appealing not just to the tech savvy, … Continue reading “The iPhone Before the Apple iPhone”
Aveo’s Ha-Ngoc to Interview Third Rock’s Mark Levin at April 4 Forum
Mark Levin, co-founder of Boston’s Third Rock Ventures, is one of the nation’s premier life sciences investors. Tuan Ha-Ngoc, founder and CEO of Aveo Pharmaceuticals, is one of the country’s leading biotech executives. Now, we are pleased to announce, the two will come together on April 4, when Ha-Ngoc will moderate a keynote chat with … Continue reading “Aveo’s Ha-Ngoc to Interview Third Rock’s Mark Levin at April 4 Forum”
Covestor Looks to Disrupt Investment Industry with “Mirror” Marketplace
If you’ve got $50K or $500K to invest with a financial advisor, you might want to check out Covestor. And well, even if you don’t, the New York-based company tells a pretty interesting story of one effort to make the field of money management more transparent. Covestor has built an online marketplace for consumers to … Continue reading “Covestor Looks to Disrupt Investment Industry with “Mirror” Marketplace”
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks
Baseball season starts this week, which means it’s time for me to spend too much time and energy on fantasy baseball. This is a strange little hobby in which millions of people use a combination of real-time data, news, and intuition to pick an imaginary team of baseball players that they hope will beat the … Continue reading “Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks”
Tracelytics Receives $5,200,001 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f5541e86-e88a-4e03-90b2-7d331451b9d7&Preview=1 Date 3/26/2012 Company Name Tracelytics Mailing Address 171 Chestnut Street 2nd Floor Providence, RI 02903 Company Description Tracelytics is the SaaS-based application performance tool that understands scalable web architectures. Erase the boundaries between applications, layers, and machines; start tracing. Website http://www.tracelytics.com Transaction Type Venture Equity Transaction Amount $5,200,001 Transaction Round Series … Continue reading “Tracelytics Receives $5,200,001 Series A Round”
Computer Science Legend David Waltz, MIT and Columbia Vet, Dies at 68
David Waltz, a legend in computer science who made major contributions to artificial intelligence and information retrieval and has strong ties to the Boston and New York areas, has died at the age of 68 of brain cancer, according to the New York Times and other reports. Waltz was a veteran of the early Cambridge, … Continue reading “Computer Science Legend David Waltz, MIT and Columbia Vet, Dies at 68”
An Evangelist Makes the Case for Google+
Guy Kawasaki, the Silicon Valley entrepreneur and investor who first rose to notoriety as chief evangelist for Apple back in the early days of the Macintosh, has found something new to evangelize. He’s just published an e-book about Google+ called What the Plus: Google+ for the Rest of Us. At a trim 180 pages, including … Continue reading “An Evangelist Makes the Case for Google+”
Glaxo and J&J’s Shrewd Move Will Help the Biotech Ecosystem
Index Ventures made news recently when it announced a new €150 million fund to invest in early-stage, life science companies. With many venture firms scaling back or exiting the business entirely, any successful fundraising is good news. However, two aspects made the announcement from Index particularly noteworthy: first, the fund is focused on early-stage innovation, … Continue reading “Glaxo and J&J’s Shrewd Move Will Help the Biotech Ecosystem”
Life Sciences News: Slow-Growing Valuations & Merck/Ariad Drug
Funding news, FDA updates, and valuations data made up the New England life sciences news this week. —Waltham, MA-based Kala Pharmaceuticals is developing drugs with special coatings that break through the body’s thick mucus to treat conditions like cystic fibrosis and ocular disease. It just came out of a two-year-long stealth mode, announcing a $6.2 million … Continue reading “Life Sciences News: Slow-Growing Valuations & Merck/Ariad Drug”
The Supreme Court’s Bad Precedent for Innovation
The Supreme Court’s ruling this week in Prometheus vs Mayo that medical tests relying on correlations between drug dosages and treatment are non-patentable portends a dramatic and frightening reduction in patent protection for innovations in the life sciences and bio-technology industries – and beyond. The Court held that San Diego-based Prometheus Laboratories’ patent claim for … Continue reading “The Supreme Court’s Bad Precedent for Innovation”
Celtra Brings Rich Media to Brands on Facebook, Sees Everything Going Mobile
What’s Facebook’s mobile strategy going to be? How are brands going to take advantage of the mobile medium? These are some of the biggest outstanding questions in the tech-business arena. We’re getting a glimpse of some of the answers this week—and a Boston startup is directly involved in helping brands navigate these issues. Celtra, a … Continue reading “Celtra Brings Rich Media to Brands on Facebook, Sees Everything Going Mobile”
Lockheed Martin’s India Innovation Program Offers Key IP, Licensing Insights
Last Friday marked the end of the five day long DST-Lockheed Martin India Innovation Growth Program workshop (LMIIGP) that took place in Goa, India, and brought together a group of fifty promising entrepreneurs and inventors. Organized by the Indian Department of Science and Technology, the Federation of Indian Chambers of Commerce and Industry (FICCI), The … Continue reading “Lockheed Martin’s India Innovation Program Offers Key IP, Licensing Insights”
Grant Funding Helps Karyopharm Speed Lead Cancer Drug to Clinic
In January 2011, Natick, MA-based Karyopharm’s 12 employees learned that the Multiple Myeloma Research Foundation would be awarding them $1 million in research funding—a giant sum considering most grants from non-profits are in the low- to mid-six-figure range. “One of the reasons it was such a substantial amount is that the grant program is focused on … Continue reading “Grant Funding Helps Karyopharm Speed Lead Cancer Drug to Clinic”
Xconomist of the Week: Linda Rottenberg on Global Tech Boom
Tech blogs typically cover startups in North America and Europe that want to be the next Facebook-style success, but the innovation ecosystem is far more diverse and far-reaching. Linda Rottenberg, CEO and co-founder of New York nonprofit Endeavor Global, has spent the last 15 years or so championing an effort to connect mentors and investors … Continue reading “Xconomist of the Week: Linda Rottenberg on Global Tech Boom”
Persimmon Technologies Secures $1,999,999 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d5bc3b67-a4bc-4a68-bd93-cec257b99f2b&Preview=1 Date 3/22/2012 Company Name Persimmon Technologies Mailing Address 200 Harvard Mill Square Wakefield, MA 01880 Company Description Persimmon’s vision is to build the largest vacuum robotics company serving the Semiconductor, LED and Solar markets by 2020 in addition to growing Nidec Sankyo’s atmospheric robot business to the top market position by … Continue reading “Persimmon Technologies Secures $1,999,999 New Funding Round”
BioRelix Secures $2,558,096 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0467c7d8-a0f3-4ad7-bb50-c2e5b28658e4&Preview=1 Date 3/22/2012 Company Name BioRelix Mailing Address 5 Science Park 401 Winchester Avenue New Haven, CT 06511 Company Description BioRelix, Inc. is a market-driven company that discovers and develops antibiotics that target pathogens resistant to currently available drugs. BioRelix’ competitive advantage resides in the use of novel patented bacterial RNA targets … Continue reading “BioRelix Secures $2,558,096 New Financing Round”
Xconomy Launches Mobile Channel
Coming on the heels of a fantastic, jam-packed Mobile Madness 2012 event last Wednesday here in Cambridge, MA, Xconomy is pleased to announce the official debut of our new Mobile Channel. The mobile sector—from apps to iPads—has been a growing part of our daily coverage. Our Mobile Madness conference, meanwhile, has been a mainstay in … Continue reading “Xconomy Launches Mobile Channel”
Y Combo-Backed HBS Startup Shoptiques Launches E-Commerce Site
Olga Vidisheva started Shoptiques during her second year at Harvard Business School to give shoppers online access to the curated inventory from independent boutiques around the world. She’s since generated some pretty serious interest—12,000 people on the private beta site’s wait list, to be exact. The site has officially opened up to the public today, … Continue reading “Y Combo-Backed HBS Startup Shoptiques Launches E-Commerce Site”
Boston’s OpenView Nabs $200 Million for Oversubscribed Third Fund
[Corrected 3/22/12, 5:40 pm. See below.] March is shaping up to be pretty sunny in Boston, both on the weather and the venture fundraising fronts. Boston-based OpenView Venture Partners is announcing today that it just closed a $200 million third fund, surpassing its initial $150 million target and securing all of its commitments in three … Continue reading “Boston’s OpenView Nabs $200 Million for Oversubscribed Third Fund”
Boston’s Deal News: Amazon Acquires Kiva, and Tech IPOs
A few big acquisitions for tech players colored the New England deals news this week: —Dublin-based pharmaceutical company Shire, which has operations in the Boston area, acquired San Francisco startup Ferrokin Biosciences for an upfront payment of $100 million and a potentially $225 million more in development and commercial milestones. Ferrokin is developing a drug … Continue reading “Boston’s Deal News: Amazon Acquires Kiva, and Tech IPOs”
SilverRail Technologies Garners $15,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dd1b7e63-e07b-4b56-b11f-4a6f4e499a82&Preview=1 Date 3/21/2012 Company Name SilverRail Technologies Mailing Address 300 Trade Center Woburn, MA 01801 Company Description SilverRail connects the world of rail. We specialize in building best-in-class technical solutions that help Railways and Travel Distributors to easily connect with each other. Website http://www.silverrailtech.com Transaction Type Venture Equity Transaction Amount $15,000,000 Transaction … Continue reading “SilverRail Technologies Garners $15,000,000 Series B Round”
Harvest Power Receives $110,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0f34b1a8-e058-4ea6-8ec2-59876087cbc4&Preview=1 Date 3/21/2012 Company Name Harvest Power Mailing Address 221 Crescent St Waltham, MA 02453 Company Description Harvest’s superpowered products and capabilities give us the opportunity to create a new life-cycle for organics. We assist communities with source separation programs, build renewable energy facilities and utilize our best-in-class technologies to produce high-quality … Continue reading “Harvest Power Receives $110,000 New Financing Round”
Thermedical Lands $1,500,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=37839d72-83e2-4cb3-8195-ff407d81f8c7&Preview=1 Date 3/21/2012 Company Name Thermedical Mailing Address 35 Medford Street Somerville, MA 02143 Company Description THERMEDICAL is developing preclinical prototypes for Saline-Enhanced Radio Frequency (SERF) ablation systems. Website http://www.thermedical.com Transaction Type Venture Equity Transaction Amount $1,500,000 Transaction Round Series A Proceeds Purposes The financing will fund continued research and development, and … Continue reading “Thermedical Lands $1,500,000 Series A Round”
Innovatient Solutions Lands $735,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4a7c60f1-cd48-4d4e-ad1b-0487c06e41ad&Preview=1 Date 3/21/2012 Company Name Innovatient Solutions Mailing Address 400 Farmington Avenue Farmington, CT 06032 Company Description Innovatient Solution’s nVision Information Therapy Solution provides the quality care management tools to dramatically improve the patient experience. Website http://www.innovatient.com Transaction Type Venture Equity Transaction Amount $735,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were … Continue reading “Innovatient Solutions Lands $735,000 New Round”
Ariad and Merck Face Tough FDA Review of Sarcoma Pill
[Updated 3/20/12, 4:30 p.m. See below.] On Friday, investigators at the FDA released a report raising a serious question about a sarcoma drug co-developed by Merck and Ariad Pharmaceuticals that’s now up for approval: Does its modest effect on tumors justify its potentially toxic side effects? This afternoon an advisory panel to the FDA will … Continue reading “Ariad and Merck Face Tough FDA Review of Sarcoma Pill”
Biotech Lagging Behind Go-Go Web Valuations, Survey Says
Developing the latest breakthrough drug just doesn’t pay these days as much as creating the hot new web app does. Private life sciences companies in Silicon Valley that got financing in the fourth quarter of 2011 had an average per-share value that was about 10 percent higher than their previous round of financing, which typically … Continue reading “Biotech Lagging Behind Go-Go Web Valuations, Survey Says”
Five Facts about Mendix, Another Cloud Enterprise App Startup
Take a look at Mendix and you’ll see some oft-buzzed-about themes. It’s a platform-as-a-service company that’s looking to disrupt the existing world of enterprise IT. Its technology is built around the cloud. And it’s located in Boston’s “Innovation District” Mendix was dreamt up by CEO Derek Roos as a means for employees at big companies … Continue reading “Five Facts about Mendix, Another Cloud Enterprise App Startup”
EMC-Isilon Acquires Storage Software Partner Likewise
One of the biggest recent acquisitions in the Seattle area is paying some more dividends today. EMC’s Isilon storage division, which was added to the IT behemoth in a $2.25 billion deal two years ago, is now acquiring Bellevue, WA-based Likewise Software. No price was given in the announcement from Likewise CEO Barry Crist, and … Continue reading “EMC-Isilon Acquires Storage Software Partner Likewise”
Amazon Buying Warehouse Tech Company Kiva Systems for $775M
Updated 3:30 pm Pacific Amazon.com is calling on armies of robots to help it get the most out of a rapidly expanding national distribution system—and those robots already work for some other well-known names in retail. The Seattle e-commerce pioneer (NASDAQ: [[ticker:AMZN]]) announced Monday that it plans to buy Kiva Systems, a supplier of planning … Continue reading “Amazon Buying Warehouse Tech Company Kiva Systems for $775M”
Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases
Mucus may be the butt of many a second grader’s jokes, but it actually plays a vital biological role—protecting our organs from harmful foreign particles by trapping them and shuttling them out of the body. Sometimes, though, mucus itself becomes the problem. In the lung disease cystic fibrosis, for example, super-thick mucus impedes breathing and … Continue reading “Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases”
Top 10 Quotes From Mobile Madness: Apple Vs. Facebook, OLPC, & More
Hello, I am a recovering Mobile Madness 2012 organizer. I’d like to give huge props to the 350+ people who attended and participated last week, and very special thanks to our speakers, sponsors, and host, Microsoft NERD. (The day is depicted in photos here.) It was a memorable afternoon indeed. So memorable, in fact, that … Continue reading “Top 10 Quotes From Mobile Madness: Apple Vs. Facebook, OLPC, & More”
Biotech’s New Frontier: Europe?
Plenty of places in the world are messed up, but Europe has been near the top of the list lately. If all the horrible scenarios play out, this will be the year the euro collapses, the European Union fractures, and some economically advanced countries could go bust. Yet while the world financial system holds its … Continue reading “Biotech’s New Frontier: Europe?”
Xconomy Mobile Madness 2012: Total Mobility in Pictures
There may be fervor around college basketball this month, but we’d like to think we drum up some pretty intense excitement around the mobile industry in March. Xconomy held its fourth Mobile Madness forum on Wednesday at Microsoft’s New England Research and Development Center in Cambridge, MA. Audience members packed in to hear the massively … Continue reading “Xconomy Mobile Madness 2012: Total Mobility in Pictures”
Sanofi Acquires Pluromed for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d1058d00-b31a-4262-b061-e33bd23b4498&Preview=1 Date 3/19/2012 Company Name Pluromed Mailing Address 175-F New Boston Street Woburn, MA 01801 Company Description Pluromed, Inc. is an early-stage medical technology company pioneering the use of injectable plugs to improve the safety, efficacy and economics of medical interventions. The Company develops, manufactures and markets a family of disposable medical … Continue reading “Sanofi Acquires Pluromed for Undisclosed Sum”
Amazon.com Acquires Kiva Systems for $775,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9f5368ec-baee-4b2f-bded-2020514d881d&Preview=1 Date 3/19/2012 Company Name Kiva Systems Mailing Address 300 Riverpark Dr. North Reading, MA 01864 Company Description Kiva is focused on solving real problems in the supply chain. CEO and Founder Mick Mountz experienced the challenges of existing material handling systems first hand while working at online grocer Webvan. Website http://www.kivasystems.com … Continue reading “Amazon.com Acquires Kiva Systems for $775,000,000”
Tokyo Electron Acquires NEXX Systems for $206,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7a0d33a7-1c01-4814-bff3-bc58e10f7805&Preview=1 Date 3/18/2012 Company Name NEXX Systems Mailing Address 900 Middlesex Turnpike Bldg. 6 Billerica, MA 01821 Company Description NEXX Systems was founded in August 2001 through the acquisition from MKS Instruments of the ASTeX systems group. The sale comprised the purchase of the Nimbus product line of sputter deposition systems and … Continue reading “Tokyo Electron Acquires NEXX Systems for $206,000,000”
Ex-Vertica/HP Honcho Lynch Talks Next Steps, New Big Data Investments
“I’m a fighter. I’m only happy when I’m in some kind of battle.” That would be Chris Lynch, the former CEO of Vertica Systems, the Cambridge, MA-based data analytics firm acquired by Hewlett-Packard for some $300 million a year ago. Lynch is looking for his next battle right now, since he left HP and Vertica … Continue reading “Ex-Vertica/HP Honcho Lynch Talks Next Steps, New Big Data Investments”
Former CEO Chris Lynch Out at Vertica/HP: What’s Next?
The golden handcuffs are off, it appears. Chris Lynch, the former CEO of Vertica, the big-data analytics company acquired by Hewlett-Packard a year ago, has left the company. The news was first reported by SiliconAngle this morning. It’s not a big surprise—CEOs leaving a year after being acquired is one of the more predictable things … Continue reading “Former CEO Chris Lynch Out at Vertica/HP: What’s Next?”
Bikes and Business: Can Cities Cycle Their Way To Prosperity?
I’ve been in Boston this week, attending Xconomy’s big Mobile Madness conference and hanging out with my colleagues in our Cambridge, MA, headquarters. For all the debate among startup entrepreneurs about whether Boston or Silicon Valley is a better place to start a company, I’ve been reminded during my visit that Boston has a huge … Continue reading “Bikes and Business: Can Cities Cycle Their Way To Prosperity?”
In Boston Life Sciences News: Akili, Kala, And Genocea
Drug developers and a new health-focused video game startup made the New England life sciences news this week. Yes, you read that correctly. —Akili Interactive Labs is hoping to be the first with a video game approved by the FDA as a medical device. The startup was founded by Boston’s PureTech Ventures and draws on … Continue reading “In Boston Life Sciences News: Akili, Kala, And Genocea”
Lumeris Acquires NaviNet for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4c35167e-3e91-4e06-b023-c58b77491ed2&Preview=1 Date 3/16/2012 Company Name NaviNet Mailing Address 179 Lincoln Street Boston, MA 02111 Company Description NaviNet was founded in 1998 on the basis that America’s healthcare industry can be made more inclusive, transparent and cost-effective by connecting providers, health plans and industry partners in real-time. Website http://www.navinet.net Transaction Type M&A Transaction … Continue reading “Lumeris Acquires NaviNet for Undisclosed Sum”
Tepha Obtains $11,346,654 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e70e2f6-ea06-4f12-aa26-6fcce75a6a3b&Preview=1 Date 3/16/2012 Company Name Tepha Mailing Address 99 Hayden Avenue East Wing Lexington, MA 02421 Company Description Tepha is a medical device firm engaged in the development of a new range of absorbable devices for therapeutic applications. Website http://www.tepha.com Transaction Type Venture Equity Transaction Amount $11,346,654 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Tepha Obtains $11,346,654 New Round”
How the NY Times Got the JOBS Act Wrong
One of the great dilemmas in the modern economy is balancing risk and reward, cost and benefit. That is true for investors, corporate managers, citizens, and elected officials. The financial crisis was caused by excessive risk taking by almost every player in the system. Investors stretched for return but didn’t understand the risks to which … Continue reading “How the NY Times Got the JOBS Act Wrong”
Demandware IPO Latest in Series of Boston Tech Breakouts
Ho-hum, another Boston-area technology IPO. This time it’s Demandware (NYSE: [[ticker:DWRE]]), the Burlington, MA-based digital retail and commerce firm. I am being ironic, because, like TripAdvisor (NASDAQ: [[ticker:TRIP]]) and Brightcove (NASDAQ: [[ticker:BCOV]]) before it, Demandware’s going public has not gotten as much in-depth attention from the press and innovation community as it probably should have. … Continue reading “Demandware IPO Latest in Series of Boston Tech Breakouts”
Shire Shells Out $100M to Buy Ferrokin Biosciences
Shire, the Dublin-based pharmaceutical company with operations in the Boston area, is paying $100 million upfront for a little San Francisco company seeking to help patients get rid of excessive amounts of iron in the blood. Shire said today it is has agreed to pay $100 million upfront, plus another $225 million if future development … Continue reading “Shire Shells Out $100M to Buy Ferrokin Biosciences”
Xconomist of the Week: Rapundalo on How the Affordable Care Act May Thwart Innovation
Stephen Rapundalo, head of the industry association MichBio, has been spending some time on Capitol Hill recently lobbying Michigan’s congressional delegation to repeal parts of the Affordable Care Act, which he says will have a chilling effect on innovation in Michigan’s nascent medical device sector. Along with representatives from 18 other states’ med-tech associations—including the … Continue reading “Xconomist of the Week: Rapundalo on How the Affordable Care Act May Thwart Innovation”
Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum
In 2010, biotech entrepreneur Chip Clark was looking for a new challenge after the company he co-founded, Vanda Pharmaceuticals in Washington, DC, completed a $200 million licensing deal with Novartis. When he was offered the opportunity to join Cambridge, MA-based vaccine developer Genocea Biosciences, he jumped. “I was acutely sensitive to the notion that the … Continue reading “Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum”
Appguppy Lands $18,000 Seed Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=04e142e3-b071-4e41-8a58-ce5809af6860&Preview=1 Date 3/15/2012 Company Name Appguppy Mailing Address Undisclosed Brookline, MA 02445 Company Description Meet Appguppy, the easiest way to go mobile. Appguppy is an online tool that lets you build your own mobile app and distribute it outside of app stores. It’s fast and easy! And with no more app stores, … Continue reading “Appguppy Lands $18,000 Seed Funding Round”